News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
522,096 Results
Type
Article (26453)
Company Profile (362)
Press Release (495258)
Multimedia
Podcasts (77)
Webinars (16)
Section
Business (148048)
Career Advice (870)
Deals (25764)
Drug Delivery (65)
Drug Development (66759)
Employer Resources (96)
FDA (12402)
Job Trends (11110)
News (252272)
Policy (19478)
Tag
Academia (2073)
Accelerated approval (14)
Adcomms (18)
Allergies (93)
Alliances (41480)
ALS (119)
Alzheimer's disease (1314)
Antibody-drug conjugate (ADC) (176)
Approvals (12487)
Artificial intelligence (367)
Autoimmune disease (38)
Automation (23)
Bankruptcy (194)
Best Places to Work (9707)
BIOSECURE Act (12)
Biosimilars (91)
Biotechnology (285)
Bladder cancer (108)
Brain cancer (37)
Breast cancer (402)
Cancer (3195)
Cardiovascular disease (239)
Career advice (773)
Career pathing (18)
CAR-T (197)
CDC (13)
Cell therapy (546)
Cervical cancer (26)
Clinical research (55790)
Collaboration (1202)
Company closure (4)
Compensation (642)
Complete response letters (36)
COVID-19 (1790)
CRISPR (74)
C-suite (449)
Cystic fibrosis (118)
Data (3417)
Decentralized trials (2)
Denatured (22)
Depression (76)
Diabetes (307)
Diagnostics (5310)
Digital health (26)
Diversity (5)
Diversity, equity & inclusion (31)
Drug discovery (161)
Drug pricing (62)
Drug shortages (11)
Duchenne muscular dystrophy (167)
Earnings (56897)
Editorial (25)
Employer branding (11)
Employer resources (86)
Events (85049)
Executive appointments (881)
FDA (14393)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1052)
Gene editing (157)
Generative AI (25)
Gene therapy (425)
GLP-1 (608)
Government (2577)
Grass and pollen (3)
Guidances (303)
Healthcare (15166)
HIV (34)
Huntington's disease (30)
IgA nephropathy (48)
Immunology and inflammation (157)
Immuno-oncology (11)
Indications (43)
Infectious disease (1943)
Inflammatory bowel disease (161)
Inflation Reduction Act (9)
Influenza (70)
Intellectual property (142)
Interviews (129)
IPO (12637)
IRA (18)
Job creations (1824)
Job search strategy (661)
Kidney cancer (14)
Labor market (30)
Layoffs (347)
Leadership (18)
Legal (3240)
Liver cancer (75)
Longevity (11)
Lung cancer (479)
Lymphoma (212)
Machine learning (20)
Management (31)
Manufacturing (422)
MASH (110)
Medical device (11029)
Medtech (11045)
Mergers & acquisitions (13923)
Metabolic disorders (765)
Multiple sclerosis (98)
NASH (17)
Neurodegenerative disease (142)
Neuropsychiatric disorders (37)
Neuroscience (2079)
NextGen: Class of 2025 (5143)
Non-profit (3151)
Now hiring (32)
Obesity (341)
Opinion (183)
Ovarian cancer (110)
Pain (133)
Pancreatic cancer (137)
Parkinson's disease (197)
Partnered (21)
Patents (319)
Patient recruitment (243)
Peanut (48)
People (45053)
Pharmaceutical (56)
Pharmacy benefit managers (12)
Phase I (18555)
Phase II (25139)
Phase III (17631)
Pipeline (2226)
Policy (121)
Postmarket research (1438)
Preclinical (7689)
Press Release (55)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (264)
Rare diseases (511)
Real estate (3865)
Recruiting (32)
Regulatory (16176)
Reports (26)
Research institute (2001)
Resumes & cover letters (105)
Rett syndrome (11)
RNA editing (15)
RSV (36)
Schizophrenia (105)
Series A (175)
Series B (134)
Service/supplier (10)
Sickle cell disease (69)
Special edition (17)
Spinal muscular atrophy (128)
Sponsored (31)
Startups (2941)
State (2)
Stomach cancer (14)
Supply chain (66)
Tariffs (28)
The Weekly (54)
Vaccines (531)
Venture capital (54)
Weight loss (188)
Women's health (41)
Worklife (9)
Date
Today (43)
Last 7 days (344)
Last 30 days (1925)
Last 365 days (28511)
2025 (19732)
2024 (32097)
2023 (35938)
2022 (45762)
2021 (48588)
2020 (45204)
2019 (37068)
2018 (27471)
2017 (26083)
2016 (23826)
2015 (27677)
2014 (20675)
2013 (16392)
2012 (17193)
2011 (17226)
2010 (15291)
Location
Africa (421)
Alabama (75)
Alaska (6)
Arizona (139)
Arkansas (11)
Asia (30104)
Australia (4828)
California (7883)
Canada (2231)
China (729)
Colorado (327)
Connecticut (357)
Delaware (216)
Europe (69264)
Florida (1166)
Georgia (276)
Hawaii (2)
Idaho (48)
Illinois (568)
India (32)
Indiana (388)
Iowa (17)
Japan (245)
Kansas (109)
Kentucky (29)
Louisiana (11)
Maine (39)
Maryland (947)
Massachusetts (5842)
Michigan (230)
Minnesota (462)
Mississippi (4)
Missouri (98)
Montana (31)
Nebraska (16)
Nevada (82)
New Hampshire (68)
New Jersey (2068)
New Mexico (27)
New York (2102)
North Carolina (1186)
North Dakota (10)
Northern California (3547)
Ohio (256)
Oklahoma (18)
Oregon (37)
Pennsylvania (1633)
Puerto Rico (14)
Rhode Island (40)
South America (644)
South Carolina (41)
South Dakota (1)
Southern California (3018)
Tennessee (121)
Texas (1163)
United States (28403)
Utah (204)
Virginia (195)
Washington D.C. (57)
Washington State (639)
West Virginia (4)
Wisconsin (83)
522,096 Results for "hitachi chemical advanced therapeutics solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi.
June 18, 2024
·
3 min read
Press Releases
Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
September 4, 2025
·
3 min read
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
Press Releases
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
April 30, 2025
·
3 min read
Press Releases
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
September 4, 2025
·
4 min read
Press Releases
Kodiak Sciences to Present at American Chemical Society Fall 2025
August 20, 2025
·
5 min read
Press Releases
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
August 4, 2025
·
1 min read
BioCapital
Elixirgen Therapeutics Enters Memorandum of Understanding with Hitachi Global Life Solutions for the Development of Micro GMP Suites for Cell Therapy Administration
Elixirgen Therapeutics, Inc. today announced that it has entered a memorandum of understanding with Hitachi Global Life Solutions, Inc. (Hitachi GLS) for the development of Micro GMP suites to facilitate cell therapy administration.
January 26, 2023
·
2 min read
Press Releases
Luna Diabetes Raises Series A Financing to Advance its Automated Insulin Delivery Solution For Insulin Pen Users
August 18, 2025
·
3 min read
Press Releases
Paragon Therapeutics Expands Executive Team to Advance Strategic Objectives
August 22, 2025
·
3 min read
1 of 52,210
Next
